Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study

doi:10.12998/wjcc.v6.i10.373

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5245)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

320

WORD

173

HTML

2135

Figures (1-4)

224

Tables (1-4)

164

Sum=3016

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

823

Download

1406

Sum=2229

Sep 26, 2018 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Sep 26, 2018; 6(10): 373-383
Published online Sep 26, 2018. doi: 10.12998/wjcc.v6.i10.373

Full Size Figure Download Figure

Figure 1 Flowchart of the study population. GC: Gastric cancer; SOX: S-1 plus oxaliplatin.¹High-risk features include poorly differentiated or higher grade cancer,lymphovascular invasion, neural invasion, or ï¼50 years of age.

Citation: Ren DF, Zheng FC, Zhao JH, Shen GS, Ahmad R, Zhang SS, Zhang Y, Kan J, Dong L, Wang ZY, Zhao FX, Zhao JD. Adjuvant chemotherapy with S-1 plus oxaliplatin improves survival of patients with gastric cancer after D2 gastrectomy: A multicenter propensity score-matched study. World J Clin Cases 2018; 6(10): 373-383
URL: https://www.wjgnet.com/2307-8960/full/v6/i10/373.htm
DOI: https://dx.doi.org/10.12998/wjcc.v6.i10.373